Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Exploratory Analysis of PASADENA Open-label Extension Evaluating the Effect of Prasinezumab on the Progression of Motor Signs and Symptoms

              Author:Pagano, Gennaro   Monnet, Annabelle   Reyes, Adriana   Simuni, Tanya   Postuma, Ronald   Pavese, Nicola   Stocchi, Fabrizio   Smigorski, Krzysztof   Gerbaldo, Valentina   Thomas, Riorge   Svoboda, Hanno   Fontoura, Paulo   Doody, Rachelle   Kerchner, Geoffrey   Brundin, Patrik   Bonni, Azad   Marek, Kenneth   Nikolcheva, Tania   

              Session Name:S30: Movement Disorders: Clinical Trials in Movement Disorders  

              Topic:Movement Disorders  

              Program Number:S30.006  

              Author Institution:Roche Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland  F. Hoffmann-La Roche Ltd, Basel, Switzerland  Northwestern University Feinberg School of Medicine, Chicago, IL  Montreal General Hospital, Montreal, QC, Canada  Newcastle University, Newcastle upon Tyne, England, United Kingdom  Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy  Excelya Germany GmbH, 78462, Germany  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Roche Diagnostics GmbH, DE, Basel, Switzerland  Invicro, A Konica Minolta Company, New Haven, CT  

              Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal a-synuclein Disease Integrated Staging System (NSD-ISS)

              Author:Tanner, Caroline   Simuni, Tanya   Chahine, Lana   Poston, Kathleen   Brumm, Michael   Chowdry, Sohini   Coffey, Christopher   Concha-Marambio, Luis   Dam, Tien   DiBiaso, Peter   Foroud, Tatiana   Frasier, Mark   Gochanour, Caroline   Jennings, Danna   Kieburtz, Karl   Kopil, Catherine   Merchant, Kalpana   Mollenhauer, Brit   Montine, Thomas   Nudelman, Kelly   Pagano, Gennaro   Seibyl, John   Sherer, Todd   Singleton, Andrew   Stephenson, Diane   Stern, Matthew   Soto, Claudio   Tolosa, Eduardo   Weintraub, Daniel   Xiao, Yuge   Siderowf, Andrew   Poewe, Werner   Marek, Kenneth   

              Session Name:P11: Movement Disorders: Parkinson's Disease Epidemiology, Genetics, and Biomarkers 2  

              Topic:Movement Disorders  

              Program Number:P11.009  

              Author Institution:University of California San Francisco, Weill Institute for Neurosciences, San Francisco, CA  Northwestern University Feinberg School of Medicien, Chicago, IL  University of Pittsburgh, Pittsburgh, PA  Stanford University, Stanford, CA  University of Iowa, Iowa City, IA  The Michael J. Fox Foundation for Parkinson's Research, New York, NY  Amprion, San Francisco, CA  Neumora Therapeutics Inc, Watertown, MA  Indiana University School of Medicine, Indianapolis, IN  Denali Therapeutics, South San Francisco, CA  University of Rochester Medical Center, Rochester, NY  Northwestern University, Chicago, IL  University of Goettingen, Goettingen, Germany  Indiana University , Indianapolis, IN  F. Hoffmann-La Roche Ltd, Basel, Switzerland  Institute for Neurodegenerative Disorders, Branford, CT  National Institute of Aging, Bethesda, MD  Critical Path Institute, Tucson, AZ  University of Pennsylvania, Philadelphia, PA  University of Texas McGovern Medical School , Houston, TX  Unviersity of Barcelona, Barcelona, Spain  University of Pennsylvania, Narberth, PA  University Hospital of Neurology, Innsbruck, Austria  Institute for Neurodegenerative Disorders, New Haven, CT